Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015.

BACKGROUND Sierra Leone has the most cases of Ebola virus disease (EVD) ever reported. Trends in laboratory-confirmed EVD, symptom presentation, and risk factors have not been fully described. METHODS EVD cases occurring from 23 May 2014 to 31 January 2015 are presented by geography, demographics, and risk factors for all persons who had laboratory-confirmed EVD, which was identified by Ebola virus-specific reverse-transcription polymerase chain reaction-based testing. RESULTS During the study period, 8056 persons had laboratory-confirmed EVD. Their median age was 28 years; 51.7% were female. Common symptoms included fever (90.4%), fatigue (88.3%), loss of appetite (87.0%), headache (77.9%), joint pain (73.7%), vomiting (71.2%), and diarrhea (70.6%). Among persons with confirmed cases, 47.9% reported having had contact with someone with suspected EVD or any sick person, and 25.5% reported having attended a funeral, of whom 66.2% reported touching the body. The incidence of EVD was highest during 1-30 November 2014, at 7.5 per 100 000 population per week, and decreased to 2.1 per week during 1-31 January 2015. Between 23 May and 30 August 2014, two districts had the highest incidence of 3.8 and 7.0 per 100 000 population per week which decreased >97% by 1-31 January 2015. In comparison, the districts that include the capital city reported a 10-fold increase in incidence per week during the same time periods. CONCLUSIONS Almost half of patients with EVD in Sierra Leone reported physical contact with a person ill with EVD or a dead body, highlighting prevention opportunities.

[1]  B. Brown,et al.  Addressing Ebola-related Stigma: Lessons Learned from HIV/AIDS , 2014, Global health action.

[2]  J. Breman,et al.  Ebola then and now. , 2014, The New England journal of medicine.

[3]  William Garvin,et al.  Surveillance for certain health behaviors among states and selected local areas--Behavioral Risk Factor Surveillance System, United States, 2011. , 2014, Morbidity and mortality weekly report. Surveillance summaries.

[4]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.

[5]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[6]  D. Bausch,et al.  Outbreak of Ebola Virus Disease in Guinea: Where Ecology Meets Economy , 2014, PLoS neglected tropical diseases.

[7]  Stuart T. Nichol,et al.  Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome , 2004, Journal of Virology.

[8]  F. Omaswa,et al.  An outbreak of Ebola in Uganda , 2002, Tropical medicine & international health : TM & IH.

[9]  P. Jahrling,et al.  ELISA for the detection of antibodies to Ebola viruses. , 1999, The Journal of infectious diseases.

[10]  N. Ndayimirije,et al.  Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). , 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.